Fermented Stevia Products: Biotransformation and Pharmaceutical Potential
ACS Food Science & Technology · 21.08.2026 · 6 (8) · 2200-2207
DOI: 10.1021/acsfoodscitech.6c00376 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Food Science & Technology, online erschienen am 15.07.2026. Verfasst von Piyali Devroy und 2 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India, Department of Science and Technology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Stevia rebaudiana (Bertoni) is well-known for its sweet compounds, the steviol glycosides, which are used as natural, noncaloric sweeteners. Fermentation processes can enhance or create compounds, particularly through the microbial biotransformation of leaves or extracts using lactic acid bacteria (LAB). Fermentation achieves 85–100% conversion of stevioside to higher-value rebaudioside forms within 24–72 h depending on LAB strain. This process produces modified metabolites with improved bioactivity, including recombinant microbial synthesis of specific glycosides such as Rebaudioside M. The pharmaceutical applications of fermented stevia products are significant, with IC50 values of 119.1 μg/mL for pancreatic cancer cells and 189.6 μg/mL for nonfermented extracts, and fermented products exhibit 2.5–3.5 times enhanced anticancer activity accompanied by antimicrobial, antioxidant, and other therapeutic effects. The safety of stevia is also notable, with it being designated as Generally Recognized as Safe. This review compiles existing data on stevia fermentation and highlights gaps in clinical applications, emphasizing potential research opportunities in oncology and infectious diseases.
Förderung
- Department of Biotechnology, Ministry of Science and Technology, India
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Devroy, P., Borah, D., & Bala, A. (2026). Fermented Stevia Products: Biotransformation and Pharmaceutical Potential. ACS Food Science & Technology, 6(8), 2200-2207. https://doi.org/10.1021/acsfoodscitech.6c00376
Vancouver
Devroy P, Borah D, Bala A. Fermented Stevia Products: Biotransformation and Pharmaceutical Potential. ACS Food Science & Technology. 2026;6(8):2200-2207. doi:10.1021/acsfoodscitech.6c00376
BibTeX
@article{Devroy2026,
author = {Devroy, Piyali and Borah, Dhrubajyoti and Bala, Asis},
title = {Fermented Stevia Products: Biotransformation and Pharmaceutical Potential},
journal = {ACS Food Science & Technology},
year = {2026},
volume = {6},
number = {8},
pages = {2200--2207},
doi = {10.1021/acsfoodscitech.6c00376}
}
EUVIMED